CYP2J2 and Parkinson disease: CYP2J2 was found to be negatively enriched in the following four pathways: complement and coagulation cascades, toll like receptor signaling pathway, hematopoietic cell lineage, and cytoking cytoking receptor interaction, and positively enriched in Parkinsons disease (Figure 6A).